Dr. Dasanu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
39000 Bob Hope Dr
Elccc - 1st Floor
Rancho Mirage, CA 92270Phone+1 760-346-7655Fax+1 760-773-1667
Education & Training
Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
BronxCare Health SystemResidency, Internal Medicine, 2000 - 2003
Nicolae Testemitanu State University of Medicine and PharmacyClass of 1991
Certifications & Licensure
CA State Medical License 2014 - 2026
CT State Medical License 2008 - 2014
WA State Medical License 2003 - 2010
ID State Medical License 2003 - 2004- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Publications & Presentations
PubMed
- Neoadjuvant Cetuximab Leading to a Complete Pathologic Response in Locally Advanced Lip Squamous Cell Carcinoma.Ruba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, David M Hyams, Constantin A Dasanu
Cureus. 2024-12-01 - Change in hair texture with the use of pomalidomide for multiple myeloma: From straight to curly phenotype.Annam Zahid, Constantin A Dasanu
Journal of Oncology Pharmacy Practice. 2024-11-25 - Temozolomide overcoming resistance to immune checkpoint inhibitors in relapsed/refractory metastatic melanoma? Insights from a single center series.Constantin A Dasanu, Steven C Plaxe
Journal of Oncology Pharmacy Practice. 2024-11-25
Press Mentions
Eyes on the HorizonJune 15th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
